Primary 4T1 Tumor Resection Provides Critical “Window of Opportunity” for Immunotherapy
Clinical and Experimental Metastasis - Netherlands
doi 10.1007/s10585-013-9619-0
Full Text
Open PDFAbstract
Available in full text
Date
October 6, 2013
Authors
Publisher
Springer Science and Business Media LLC